Amar Kishan
@amarukishan
Radiation Oncologist, Professor, and Executive Vice Chair of Radiation Oncology at UCLA. All views are my own.
ID: 929919632827232258
https://www.uclahealth.org/amar-kishan 13-11-2017 03:51:32
3,3K Tweet
3,3K Followers
781 Following
Paul Sargos Piet Ost Vedang Murthy Derya Tilki, MD Pierre Blanchard, MD Piet dirix Tyler Seibert MD PhD Sean McBride Sean Collins Prostate SBRT @ USF Health Gert De Meerleer European Association of Urology (EAU) EAU Young Academics Dr. Tamim Niazi Brian C. Baumann Michael Hofman Alberto Briganti Ploussard Guillaume Alan Dal Pra, MD SAKK 09/10 actually excluded these patients I believe, so your result is actually not inconsistent with SAKK 09/10 at all. In that trial, the failure of dose-escalation to even impact FFFP could be attributed to inherent uncertainties in localizing disease in the SRT setting.